Compare CLPT & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLPT | ISD |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.6M | 428.2M |
| IPO Year | 2009 | N/A |
| Metric | CLPT | ISD |
|---|---|---|
| Price | $10.48 | $13.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 635.4K | 94.3K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,971,000.00 | N/A |
| Revenue This Year | $45.67 | N/A |
| Revenue Next Year | $19.51 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.78 | N/A |
| 52 Week Low | $8.27 | $12.53 |
| 52 Week High | $30.10 | $14.79 |
| Indicator | CLPT | ISD |
|---|---|---|
| Relative Strength Index (RSI) | 54.06 | 47.81 |
| Support Level | $10.02 | $12.53 |
| Resistance Level | $11.74 | $14.67 |
| Average True Range (ATR) | 0.55 | 0.25 |
| MACD | 0.25 | 0.08 |
| Stochastic Oscillator | 86.29 | 81.05 |
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.